Healthcare -
Biotechnology - NASDAQ - US
$ 2.96
17.1 %
$ 14.2 M
Market Cap
-0.27
P/E
PHIO - COST OF REVENUE
Cost of Revenue PHIO - Phio Pharmaceuticals Corp.
35 K
LAST VALUE
-57.42%
2 YEAR CAGR
52.10%
5 YEAR CAGR
-39.89%
10 YEAR CAGR